Prospera Financial Services’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,085
| Closed | -$10K | – | 1797 |
|
|
2022
Q1 | $10K | Buy |
+4,085
| New | +$14.4K | ﹤0.01% | 2020 |
|
|
2021
Q2 | – | Sell |
-26,650
| Closed | -$247K | – | 797 |
|
|
2021
Q1 | $247K | Sell |
26,650
-19,634
| -42% | -$239K | 0.01% | 671 |
|
|
2020
Q4 | $833K | Buy |
+46,284
| New | +$813K | 0.06% | 327 |
|
|
2020
Q3 | – | Sell |
-96,400
| Closed | -$483K | – | 1622 |
|
|
2020
Q2 | $483K | Buy |
96,400
+73,130
| +314% | +$150K | 0.04% | 359 |
|
|
2020
Q1 | $24K | Sell |
23,270
-8,100
| -26% | -$11.4K | ﹤0.01% | 505 |
|
|
2019
Q4 | $39K | Buy |
31,370
+21,253
| +210% | +$30.3K | ﹤0.01% | 591 |
|
|
2019
Q3 | $15K | Buy |
+10,117
| New | +$19.7K | ﹤0.01% | 542 |
|
|
2018
Q2 | – | Sell |
-1,769
| Closed | -$44K | – | 453 |
|
|
2018
Q1 | $44K | Hold |
1,769
| – | – | 0.01% | 434 |
|
|
2017
Q4 | $46K | Buy |
1,769
+14
| +0.8% | +$620 | 0.01% | 391 |
|
|
2017
Q3 | $87K | Sell |
1,755
-81
| -4% | -$5.05K | 0.01% | 417 |
|
|
2017
Q2 | $156K | Sell |
1,836
-96
| -5% | -$6.18K | 0.03% | 404 |
|
|
2017
Q1 | $139K | Sell |
1,932
-111
| -5% | -$15.1K | 0.03% | 365 |
|
|
2016
Q4 | $338K | Sell |
2,043
-56
| -3% | -$13.1K | 0.07% | 249 |
|
|
2016
Q3 | $679K | Sell |
2,099
-90
| -4% | -$32.8K | 0.14% | 135 |
|
|
2016
Q2 | $714K | Sell |
2,189
-7
| -0.3% | -$2.41K | 0.15% | 124 |
|
|
2016
Q1 | $735K | Buy |
2,196
+80
| +4% | +$27.2K | 0.16% | 103 |
|
|
2015
Q4 | $823K | Buy |
2,116
+133
| +7% | +$52.1K | 0.18% | 85 |
|
|
2015
Q3 | $813K | Buy |
1,983
+570
| +40% | +$298K | 0.21% | 75 |
|
|
2015
Q2 | $1.03M | Buy |
+1,413
| New | +$1M | 0.25% | 74 |
|
Other funds holding CRDF
AG
LCM
